Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Freiha F, Reese J, Torti F (1996) A randomized trial of radical cystectomy vs. radical castectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155: 495–500
2. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MRS, Clarkson B, Oettgen HF, Alton K, Weite K, Souza L (1989) Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional carcinoma of the urothelium. N Engl J Med 318: 1414–1422
3. Gschwend J, Vieweg J, Herr HW, Fair WR (1997) Krankheitsspezifisches Überleben nach radikaler Zystektomie beim Blasenkarzinom —10 Jahre Erfahrung und Langzeit-Nachbeobachtung. Urologe [A] [Suppl] 1: 5
4. Herr HW (1989) Neoadjuvant chemotherapy for invasiv bladder cancer. Semin Surg Oncol 5: 266–271
5. Igawa M, Ohkuchi T, Ueki T, Ueda M, Okada K, Usui T (1990) Usefulness and limitations of methotrexate, vinblastine, doxorubicin and cisplatin for the treatment of advanced urothelial cancer. J Urol 144: 662–665